Advanced Basal Cell Carcinoma: What Dermatologists Need to Know About Current and Emerging Targeted Therapies
Format: Journal Supplement
Credit(s): 1.00 (60 min)
Release Date: May 13, 2022
Expiration Date: May 13, 2023
Physicians – AMA PRA Category 1 Credit(s) ™
Physicians/ABIM MOC – ABIM MOC Point(s)
Physicians/ABD MOC – ABD MOC Point(s)
While most basal cell carcinomas (BCCs) are amenable to surgery or radiotherapy, progression to locally advanced or metastatic BCC is life-threatening, difficult to treat, and not amenable to those standard options. Historically, few treatment options have been available for advanced BCC. The approval of the oral hedgehog pathway inhibitors vismodegib and sonidegib changed the treatment paradigm for patients with locally advanced and metastatic BCC. However, inadequate response or intolerance to these targeted therapies is frequent, leaving an unmet need for many patients with advanced BCC. To meet this need for additional treatment options, the anti-PD-1 therapy, cemiplimab, was recently approved for advanced BCC, and others, i.e. pembrolizumab and nivolumab, are currently in BCC clinical trials.
Advanced Basal Cell Carcinoma: What Dermatologists Need to Know About Current and Emerging Targeted Therapies will provide these clinicians with updates on treatment options, along with reinforcing the roles that dermatologists serve, e.g. monitoring and managing side effects of therapy and ensuring effective multidisciplinary management, in the care of patients with advanced BCC.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi Genzyme.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Eosinophilic Granulomatosis with Polyangiitis: Where Are We with Diagnosis and Management?
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.